Pharmaceutical manufacturers have benefited from a burgeoning elderly population in developed economies and a growing middle class in emerging economies, which have provided a larger customer base for industry operators. Many manufacturers have also tapped into regional demand for pharmaceuticals that may differ from developed markets. For example, East Asia has a high prevalence of gastric and esophageal cancer, which has incited many manufacturers to invest in research and development (R&D) for diseases that may be common in specific regions. Furthermore, the growing global middle class has provided growth opportunities as more patients can afford pharmaceuticals.
This industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms including ampoules, tablets, capsules, vials, ointments, powders, solutions and suspensions. The overall pharmaceutical market can be segmented into prescription-based (or ethical) products and over-the-counter medications. Industry products are predominantly distributed via wholesalers, and are then sold via pharmacies or distributed in hospitals.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.
